- Home
- Clinical Trials
COPD Study Sydney SL 82
COPD Study
St Leonards Sydney
Do you have COPD with ongoing symptoms?
You may be eligible to join a clinical research study testing a potential new treatment option for COPD.
By joining, you may receive early access to a potential new treatment, receive regular health checks, and help contribute to research that could benefit others living with COPD.
Description
What to expect
Study details
Ages
40 to 75 years old
Duration
Up to 32 weeks and involves 10 scheduled clinic visits
Compensation
Participants will be compensated for reasonable expenses associated with study visits
Eligibility Criteria
You may qualify if you:
- Are between 40 and 75 years old
- Have been diagnosed with COPD for at least 12 months
- Are currently taking two or more daily inhaled medications for COPD.
- Are a former cigarette smoker.
Other eligibility criteria apply. A member of our team will check if this study is a good fit for you.
Locations
Description
Chronic Obstructive Pulmonary Disease is a chronic lung condition that can make breathing difficult and reduce quality of life. Some people with COPD have a specific type of airway inflammation called Type 2 inflammation, which may make symptoms worse.
Common symptoms include shortness of breath, coughing, wheezing and fatigue. COPD affects over 300 million people globally and can significantly limit daily activities, social interactions, and overall quality of life. Though it develops gradually, its impact can be life changing.
Current COPD treatment aims to relieve symptoms, improve breathing, and prevent flare ups. These include inhalers, medications, pulmonary rehabilitation and in some cases, oxygen therapy.
This study is exploring a potential new treatment aimed at targeting a specific type of inflammation found in some people with COPD. By better understanding and treating this inflammatory pathway, researchers hope to improve breathing, slow disease progression, and enhance quality of life.
What to expect
As a participant you will be randomly assigned to receive either:
- The investigational medication
- A placebo
All participants will continue their standard of care for COPD.
The study medication will be administered as a subcutaneous (under the skin) injection, every 4 weeks for a 12-week period. You will not know if you are receiving the study medication or placebo. You will have a 2 in 1 chance of receiving the study medication versus placebo.
You will visit the clinic regularly for health assessments, including lung function tests, symptoms check-ins, and general health monitoring. Throughout the study, our professional clinic team will closely monitor your well-being and provide support at every step.
Why join this clinical research study?
- Gain early access to new potential treatments at no cost
- Contribute to research for those living with COPD
- Learn to better manage your condition
- Receive health checks and advice from our professional medical team
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.